
UNIVERSAL DISPLAY CORP \PA\ — Investor Relations & Filings
Universal Display Corporation is a leader in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials. The company operates as an innovator, patent licensor, and materials supplier for the OLED market. It specializes in inventing and supplying advanced, energy-efficient phosphorescent OLED (PHOLED) materials and technologies. These proprietary components are integral to the manufacturing of high-performance displays for a wide array of consumer electronics, including smartphones, televisions, wearables, and tablets, as well as for solid-state lighting applications.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Subject) | 2026-03-27 | English | |
| 10-K - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | |
| 8-K - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | |
| 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | |
| 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | |
| 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 33064229 | SCHEDULE 13G/A - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Subject) | 2026-03-27 | English | ||
| 32885140 | 10-K - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885139 | 8-K - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885134 | 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885135 | 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885136 | 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885137 | 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885138 | 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 26179944 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 26180234 | 4 Filing | 2026-02-03 | English | ||
| 26180628 | 4 Filing | 2026-01-05 | English | ||
| 26180530 | 4 Filing | 2026-01-05 | English | ||
| 26180327 | 4 Filing | 2026-01-05 | English | ||
| 26180319 | 4 Filing | 2026-01-05 | English | ||
| 26180145 | 4 Filing | 2026-01-05 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Oxurion NV
Acquires majority stakes in European pharmaceutical subcont…
|
OXUR | BE | Professional, scientific and te… |
|
PACIFIC EDGE LIMITED
Develops non-invasive molecular tests for bladder cancer de…
|
PEB | NZ | Professional, scientific and te… |
|
PARADIGM BIOPHARMACEUTICALS LIMITED..
Repurposing PPS for osteoarthritis and rare inflammatory di…
|
PAR | AU | Professional, scientific and te… |
|
Pasithea Therapeutics Corp.
Develops treatments for central nervous system disorders, R…
|
KTTA | US | Professional, scientific and te… |
|
Passage BIO, Inc.
A clinical-stage genetic medicines company developing thera…
|
PASG | US | Professional, scientific and te… |
|
PATRYS LIMITED
Develops Deoxymab antibody therapies targeting DNA repair m…
|
PAB | AU | Professional, scientific and te… |
|
PAVmed Inc.
A diversified medical technology company developing devices…
|
PAVM | US | Professional, scientific and te… |
|
PegBio Co., Ltd.
Specializes in discovering and developing innovative therap…
|
2565 | HK | Professional, scientific and te… |
|
PELL BMT
Develops advanced cell and gene therapies, including CAR-T …
|
6949 | TW | Professional, scientific and te… |
|
PepGen Inc.
Develops oligonucleotide therapeutics for neuromuscular and…
|
PEPG | US | Professional, scientific and te… |
UNIVERSAL DISPLAY CORP \PA\ via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30834/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30834 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30834 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30834 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30834}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for UNIVERSAL DISPLAY CORP \PA\ (id: 30834)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.